Biogen Inc. (BIIB)

316.73
NASDAQ : Health Technology
Prev Close 326.70
Day Low/High 316.15 / 326.55
52 Wk Low/High 249.17 / 388.67
Avg Volume 1.24M
Exchange NASDAQ
Shares Outstanding 201.48M
Market Cap 65.82B
EPS 11.90
P/E Ratio 21.15
Div & Yield N.A. (N.A)

Latest News

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

Jim Cramer's been saying that that if the Fed or the president blink in their wars against inflation and China you could have an up day. That's what we got.

Colgate-Palmolive, Biogen Idec, Covanta: 'Mad Money' Lightning Round

Colgate-Palmolive, Biogen Idec, Covanta: 'Mad Money' Lightning Round

Jim Cramer weighs in on Colgate-Palmolive, Biogen Idec, Covanta, Cypress Semiconductor, Carrizo Oil & Gas, Allstate and more.

Biogen Becomes #41 Most Shorted Nasdaq 100 Component, Replacing Booking Holdings

Biogen Becomes #41 Most Shorted Nasdaq 100 Component, Replacing Booking Holdings

The most recent short interest data has been released for the 10/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Spirit Airlines, Southwest, Amgen: 'Mad Money' Lightning Round

Spirit Airlines, Southwest, Amgen: 'Mad Money' Lightning Round

Jim Cramer weighs in on Spirit Airlines, Southwest, Amgen, Biogen Idec, Liberty Oilfield Services, The Chefs Warehouse, Under Armour and more.

Reasons for This Rally: Cramer's 'Mad Money' Recap (Tuesday 9/18/18)

Reasons for This Rally: Cramer's 'Mad Money' Recap (Tuesday 9/18/18)

Jim Cramer says news on tariffs, FANG stocks, positive research, and the corporate outlook are fueling a stock market surprise.

Why Investors Should Favor Smaller Biotech Companies

Why Investors Should Favor Smaller Biotech Companies

Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.

Dow Ends Off 125 Points as Caterpillar, 3M Earnings Disappoint

Dow Ends Off 125 Points as Caterpillar, 3M Earnings Disappoint

The Dow Jones Industrial Average falls Tuesday after earnings disappoint. The S&P 500 falls for the 12th time in 14 sessions.

Stocks Sink, Caterpillar, McDonald's, Arconic and Bayer - 5 Things You Must Know

Stocks Sink, Caterpillar, McDonald's, Arconic and Bayer - 5 Things You Must Know

U.S. stock futures tumble sharply as investors focus on slowing economic growth and simmering geopolitical tensions; Caterpillar, McDonald's, Verizon and 3M report earnings; Arconic is mulling an $11 billion offer from Apollo, a report says; a judge cuts the jury award against Bayer's Roundup.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Biogen Becomes #36 Most Shorted Nasdaq 100 Component, Replacing Twenty-First Century Fox

Biogen Becomes #36 Most Shorted Nasdaq 100 Component, Replacing Twenty-First Century Fox

The most recent short interest data has been released for the 08/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Big Swings in Biogen Make It Hard to Take New Positions

Big Swings in Biogen Make It Hard to Take New Positions

Short-term price action may be volatile, but this name is still bullish long term.

The Race to Cure Alzheimer's is On: These Are the Forerunners

The Race to Cure Alzheimer's is On: These Are the Forerunners

Top pharmaceutical companies are paving the way to a cure for Alzheimer's, a degenerative disease that is affecting millions around the world.

Biogen Shares Plummet Despite Alzheimer's Drug Exceeding Expectations

Biogen Shares Plummet Despite Alzheimer's Drug Exceeding Expectations

Shares fell by more than 11% in after hours trading Wednesday.

3 Investments You Are Probably Not Considering, But Should Be

3 Investments You Are Probably Not Considering, But Should Be

Even with the market looking wobbly, there are good bargains to be found. Here are several suggestions from TheStreet's newsroom.

Biogen's Big Alzheimer's Presentation on Wednesday: What You Need to Know

Biogen's Big Alzheimer's Presentation on Wednesday: What You Need to Know

The biotech giant will present detailed results of its mid-stage trials of BAN2401 at the Alzheimer's Association International Conference in Chicago.

Jim Cramer: We've Got an Extremist Market

Jim Cramer: We've Got an Extremist Market

Don't buy up when there's nothing but rampant pin action.

Dow Breaks 3-Day Skid; Nasdaq Rebounds to End Flat

Dow Breaks 3-Day Skid; Nasdaq Rebounds to End Flat

The Dow ended higher, breaking a 3-day skid, while the Nasdaq rebounded to end little changed after hitting a record high earlier.

Biogen Jumps on Earnings Beat Ahead of Alzheimer's Presentation

Biogen Jumps on Earnings Beat Ahead of Alzheimer's Presentation

The biotech giant also raised its 2018 guidance for both revenue and earnings.

Alphabet, AT&T, Verizon and New York Daily News - 5 Things You Must Know

Alphabet, AT&T, Verizon and New York Daily News - 5 Things You Must Know

U.S. stock futures rise on Tuesday, with solid corporate earnings boosting shares on Wall Street; Alphabet is set to open at a record high after the parent of Google posts a significant earnings beat; AT&T and Verizon highlight Tuesday's earnings calendar.

3 Things to Watch When Biogen Reports Second-Quarter Results

3 Things to Watch When Biogen Reports Second-Quarter Results

The Cambridge, Mass.-based biotech is scheduled to unveil its second-quarter results before the market open on July 24.

Prepare for Volatility Around Biogen Ahead of Alzheimer's Presentation: Leerink

Prepare for Volatility Around Biogen Ahead of Alzheimer's Presentation: Leerink

Positive readings from the biotech giant's Alzheimer's drug could drive the stock to as high as $393.

Target, US Bancorp, BlackRock: 'Mad Money' Lightning Round

Target, US Bancorp, BlackRock: 'Mad Money' Lightning Round

Jim Cramer is bullish on Target, Biogen Idec, Regions Financial, Lockheed Martin, US Bancorp, BlackRock and more.

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Jim Cramer says financial payment companies are the most beloved in the market right now. He explains digitized payment companies. And love.

5 Big Biotech Stories to Watch

5 Big Biotech Stories to Watch

The biotech and pharmaceutical industries have had some big news in recent weeks. Here's what you should know to stay up-to-date.

2 Small Biotechs I Like in the Second Half

2 Small Biotechs I Like in the Second Half

Adamis Pharmaceuticals and Pieris Pharmaceuticals are names to watch.

TheStreet Quant Rating: B+ (Buy)